Hormonal factors in aetiopathogenesis of psoriasis;Rola hormonów w etiopatogenezie łuszczycy

Polski Merkuriusz Lekarski

Volumn 22, Issue 127, 2007, Pages 75-78

  Damasiewicz Bodzek, Aleksandra ^a   Kos KudŁA, Beata ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Prolactin; Psoriasis; Sex hormones; Somatotrophin axis hormones; Stress hormones

Indexed keywords

ANDROGEN; GROWTH HORMONE; HORMONE; PROLACTIN; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN 3;

ADOLESCENT; ADULT; ARTICLE; FEMALE; HOSPITALIZATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEWBORN EXFOLIATIVE DERMATITIS; PATHOLOGY; PREGNANCY; PSORIASIS; SKIN;

ADOLESCENT; ADULT; ANDROGENS; DERMATITIS, EXFOLIATIVE; FEMALE; GONADAL STEROID HORMONES; GROWTH HORMONE; HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MIDDLE AGED; PREGNANCY; PROLACTIN; PSORIASIS; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 33847080335     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Ahmed S.A., Penhale W.J., Talal N.: Sex hormones, immune responses and autoimmune disease - mechanisms of sex hormone actions. Am. J. Pathol., 1985, 122, 531-551.
2. Baker B.S., Fry L.: The immunology of psoriasis. Br. J. Dermatol., 1992, 126, 1-9.
3. Björntorp E., Wickelgren R., Bjarnason R. i wsp.: No evidence for involvement of the growth hormone/insulin-like growth factor-1 axis in psoriasis. J. Invest. Dermatol., 1997, 109, 661-665.
4. Boyd A.S., Morris L.F., Phillips C.M.: Psoriasis and pregnancy: hormone and immune system interaction. Int. J. Dermatol., 1996, 35, 169-172.
5. Buskila D., Sukenik S., Holcberg G. i wsp.: Improvement of psoriatic arthritis in a patient treated with bromocriptin for hyperprolactinaemia. J. Rheumatol., 1991, 18, 611-612.
6. Buskila D., Sukenik S., Shoenfeld Y.: The possible role of prolactin in autoimmunity. Am. J. Reprod. Immunol., 1991, 26, 118-123.
7. Damasiewicz-Bodzek A., Kos-Kudła B., Suwata-Jurczyk B.: Somatotrophin axis hormones in patients affected with psoriasis. Neuroendocrinol. Lett., 2005, 26, 724-728.
8. Dela Torre B., Fransson J., Scheynius A.: Blood dehydroepiandrosterone sulphate (DHEAS) levels in pemphlgoid/pemphigus and psoriasis. Clin. Exp. Rheumatol., 1995, 13, 345-348.
9. Falus A., Rakasz E., Biro J.: Neuroendocrine immunology: Regulatory interactions of inflammatory cytokines and hypothalamus-pituitary-adrenal axis. Immunologist, 1993, 1, 40-42.
10. Farber E.M., Nail M.L.: The natural history of psoriasis in 5600 patients. Dermatologica, 1974, 148, 1-18.
11. Gala R. R.: Prolactin and growth hormone in the regulation of the immune system. Proc. Soc. Exp. Biol. Med., 1991, 198, 513-527.
12. Giasuddin A.S.M., El-Sherif A.I., El-Ojali S.I.: Prolactin: does it have a role in the pathogenesis of psoriasis? Dermatology, 1998, 197, 119-122.
13. Girolomoni G., Phillips J.T., Bergstresser P.R.: Prolactin stimulates proliferation of cultured human keratinocytes. J. Invest. Dermatol., 1993, 101, 275-279.
14. Guilhou J.J.: Growth hormone, somatostatin and psoriasis. Dermatologica, 1990, 181, 81-82.
15. Hedman M., Nilsson E., De la Torre B.: Low blood and synovial fluid levels of sulpho-conjugated steroids in rheumatoid arthritis. Clin. Exp. Rheumatol., 1992, 10, 25-30.
16. Hodak E., Gottlieb A.B., Anzilotti M. i wsp.: The insulin-like growth factor 1 receptor is expresses by epithelial cells with proliferative potential in human epidermis and skin appendages: correlation of increased expression with epidermal hyperplasia. J. Invest. Dermatol., 1996, 106, 564-570.
17. Holzmann H., Benes P., Morsches B.: Dehydroepiandrosternmagel bei psoriasis. Hautarzt, 1980, 31, 71-75.
18. Hooghe-Peters E.L., Delhase M., Vergani P. i wsp.: Growth hormone and prolactin are paracrine growth and differentiation factors in the haemopoietic system. Immunol. Today, 1993, 14, 212-214.
19. Horseman N.D., Prolactin. W: Endocrinology fourth edition. De Groot L.J., Jameson J.L. (ed.). W.B. Saunders Company, Philadelphia, 2001, 209-220.
20. Iwatani Y., Amino N., Tachi J. i wsp.: Changes of lymphocyte subsets in normal pregnant and postpartum women: postpartum increase of NK/K (Leu-7) cells. Am. J. Reprod. Immunol. Microbiol., 1988, 18, 52-55.
21. Krane J.F., Gottlieb A.B., Carter D.M. i wsp.: The insulin-like growth factor I receptor is overexpresses in psioriatic epidermis, but is differentialy regulated from the epidermal growth rector receptor. J. Exp. Med., 1992, 175, 1081-1090.
22. Mackie R.M., Beastall G.M., Thomson J.A.: Growth hormone levels in psoriasis. Arch. Dermatol. Res., 1983, 275, 207-208.
23. Maghine M., Borroni G., Larizza D. i wsp.: Relapsing eruptive psoriasis and immunological changes triggered by growth hormone therapy in a growth hormone-deficient girl. Dermatologica, 1990, 181, 139-141.
24. Matt L.H., Kingston T.P., Lowe N.J.: Treatment of severe psoriasis with somatostatin. J. Dermatol. Treat., 1989, 1, 3-4.
25. Milewich L., Shaw C.B., Sontheimer R.D.: Steroid metabolism by epidermal keratinocytes. Ann. N.Y. Acad. Sci., 1988, 548, 66-89.
26. Misra P., Nickoloff B.J., Morhenn V.B. i wsp.: Characterization of insulinlike growth factor-I/ somatomedin-C receptors on human keratinocyte monolayers. J. Invest. Dermatol., 1986, 87, 264-267.
27. Mowad C.M., Margolis D.J., Halpern A.C. i wsp.: Hormonal influences on women with psoriasis. Cutis, 1998, 61, 257-260.
28. Nickoloff B.J., Misra P., Morhenn V.B. i wsp.: Further characterization of the keratinocyte somatomedin-C/insulin-like growth factor-I (SM-C/IGF1) receptor and the biological responsiveness of cultured keratinocytes to SM-C/IGF-1. Dermatologica, 1988, 177, 265-273.
29. Oakes S.R., Haynes K.M., Waters M.J. i wsp.: Demonstration and localization of growth hormone receptor in human skin and skin fibroblasts. J. Clin. Endocrinol. Metab., 1992, 75, 1368-1373.
30. Pellegrini I., Lebrun J.J., Ali S. i wsp.: Expression of prolactin and its receptor in human lymphoid cells. Mol. Endocrinol., 1992, 6, 1023-1031.
31. Pfeifle B., Ditschuneit H.: Two separate receptors for insulin and insulinlike growth factors on arterial smooth muscle cells. Exp. Clin. Endocrinol., 1983, 81, 280-286.
32. Regana M.S., Millet P.U.: Psoriasis in association with prolactinoma: three cases. Br. J. Dermatol., 2000, 143, 864-867.
33. Ristow J.H.: Increased synergistic effect of EGF and IGF-I on DNA synthesis of cultured psoriatic keratinocytes. Dermatology, 1997, 195, 213-219.
34. Rosenfeld R.G., Dollar L.A.: Characterization of the somatomedin-C/insulin-like growth factor-/ (SM-C/IGF-1) receptor on cultured human fibroblast monolayers: regulation of receptor concentrations by SM-C/IGF-1 and insulin. J. Clin. Endocrinol. Metab., 1982, 55, 434-440.
35. Schmid O.G., Jacobs R., Jager B. i wsp.: Stress-induced endocrine and immunological changes in psoriasis and healthy controls. A preliminary study. Psychother. Psychosom., 1998, 67, 37-42.
36. Schwarz W., Schnell H., Hornstein O.P. i wsp.: Testosterone serum levels in male psoriatics. Arch. Dermatol. Res., 1981, 270, 377-379.
37. Siiteri P.K., Stiles D.P.: Immunologic and endocrine interrelationships in pregnancy. Biol. Reprod., 1982, 26, 1-14.
38. Smith T., Cuzner M.L.: Neuroendocrine immune interaction in homeostasis and autoimmunity. Neuropath. Appl. Neurobiol., 1994, 20, 413-422.
39. Swanbeck G., Inerot A., Martinsson T. i wsp.: A population genetic study of psoriasis. Br. J. Dermatol., 1994, 131, 32-39.
40. Tavakkol A., Elder J.T., Griffiths C.E. i wsp.: Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J. Invest. Dermatol., 1992, 99, 343-349.
41. Todd D.J., Eedy D.J., McMillan J.C.: Acromegaly and psoriasis. Clin. Exp. Dermatol., 1991, 16, 222-223.
42. Weber G., Heitz P.U.: Cytoendocrinological findings in the pituitary glands of patients with psoriasis. Acta Endocrinol. (Copenh.), 1988, 119, 501-505.
43. Weber G., Heitz U., Pliess G.: Hyperplasia of growth hormone - producing cells in the hypophysis in psoriasis. Study of 10 patients. Hautarzt, 1986, 37, 458-462.
44. Weber G., Krughardt G., Neidhardt M. i wsp.: Treatment of psoriasis with somatostatin. Arch. Dermatol. Res., 1982, 272, 31-36.
45. Weber G., Neidhardt M., Frey H. i wsp.: Treatment of psoriasis with bromocriptin. Arch. Dermatol. Res., 1981, 271, 437-439.
46. Weber G., Neidhardt M., Schmidt A. i wsp.: Correlation of growth hormone and aetiology of psoriasis. Arch. Dermatol. Res., 1981, 270, 129-140.
47. Weber G., Pliess G., Heitz U.: Growth hormone producing hyperplasia of pituitary gland in psoriasis. Arch. Dermatol. Res., 1985, 277, 345.
48. Weigl B.A.: Immunoregulatory mechanisms and stress hormones in psoriasis (part 1). Int. J. Dermatol., 1998, 37, 350-357.
49. Weigl B.A.: The significance of stress hormones (glucocorticoids, catecholamines) for eruptions and spontaneous remission phases in psoriasis. Int. J. Dermatol., 2000, 39, 678-688.
50. Wraight C.J., White P.J., McKean S.C. i wsp.: Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor-I receptor antisense oligonucleotides. Nat. Biotechnol., 2000, 18, 521-526.